Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_1
1
25%
Ph phase_2
1
25%
Ph phase_3
1
25%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (33.3%)
Phase 21 (33.3%)
Phase 31 (33.3%)

Trials by Status

terminated125%
completed125%
unknown250%

Recent Activity

0 active trials
Showing 4 of 4
unknownphase_1

A Study to Assess PV-10 Chemoablation of Cancer of the Liver

NCT00986661
terminatedphase_3

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

NCT02288897
unknown

Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors

NCT01260779
completedphase_2

Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma

NCT00521053

Clinical Trials (4)

Showing 4 of 4 trials
NCT00986661Phase 1

A Study to Assess PV-10 Chemoablation of Cancer of the Liver

Unknown
NCT02288897Phase 3

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

Terminated
NCT01260779

Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors

Unknown
NCT00521053Phase 2

Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4